Thenalidine

Summary

Thenalidine is an antihistamine with anticholinergic properties used as an antipruritic drug.[1] It was withdrawn from the US, Canadian, and UK markets in 1963 due to a risk of neutropenia.[2]

Thenalidine
Clinical data
ATC code
Identifiers
  • 1-Methyl-N-phenyl-N-(2-thienylmethyl)piperidin-4-amine
CAS Number
  • 86-12-4 checkY
PubChem CID
  • 27901
DrugBank
  • DB04826 checkY
ChemSpider
  • 25957 ☒N
UNII
  • 6U94N2D00F
KEGG
  • D07194 checkY
CompTox Dashboard (EPA)
  • DTXSID1048835 Edit this at Wikidata
ECHA InfoCard100.001.501 Edit this at Wikidata
Chemical and physical data
FormulaC17H22N2S
Molar mass286.44 g·mol−1
3D model (JSmol)
  • Interactive image
  • s1c(ccc1)CN(c2ccccc2)C3CCN(C)CC3
  • InChI=1S/C17H22N2S/c1-18-11-9-16(10-12-18)19(14-17-8-5-13-20-17)15-6-3-2-4-7-15/h2-8,13,16H,9-12,14H2,1H3 ☒N
  • Key:KLOHYVOVXOUKQI-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

References edit

  1. ^ Getzler NA, Ereaux LP (March 1959). "Evaluation of thenalidine tratrate (sandostene) in dermatological disorders". Canadian Medical Association Journal. 80 (6): 445–8. PMC 1830689. PMID 13629433.
  2. ^ "Thenalidine". DrugBank.